Irina Rivkind Koffler
Stock Analyst
(n/a)
# 4,408
Out of 4,415 analysts
18
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EGRX Eagle Pharmaceuticals | Maintains: Neutral | n/a | $4.40 | - | 2 | Mar 22, 2019 | |
| EOLS Evolus | Maintains: Buy | n/a | $13.22 | - | 2 | Mar 19, 2019 | |
| PCRX Pacira BioSciences | Downgrades: Underperform | n/a | $27.32 | - | 2 | Feb 1, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | n/a | $30.27 | - | 2 | Dec 17, 2018 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | n/a | $14.08 | - | 5 | Sep 17, 2018 | |
| IRWD Ironwood Pharmaceuticals | Upgrades: Buy | n/a | $8.30 | - | 2 | May 2, 2018 | |
| DERM Journey Medical | Downgrades: Neutral | n/a | $3.63 | - | 2 | Mar 6, 2018 | |
| JAZZ Jazz Pharmaceuticals | Downgrades: Neutral | n/a | $109.29 | - | 1 | Apr 6, 2017 |
Eagle Pharmaceuticals
Mar 22, 2019
Maintains: Neutral
Price Target: n/a
Current: $4.40
Upside: -
Evolus
Mar 19, 2019
Maintains: Buy
Price Target: n/a
Current: $13.22
Upside: -
Pacira BioSciences
Feb 1, 2019
Downgrades: Underperform
Price Target: n/a
Current: $27.32
Upside: -
Supernus Pharmaceuticals
Dec 17, 2018
Maintains: Buy
Price Target: n/a
Current: $30.27
Upside: -
Teva Pharmaceutical
Sep 17, 2018
Maintains: Buy
Price Target: n/a
Current: $14.08
Upside: -
Ironwood Pharmaceuticals
May 2, 2018
Upgrades: Buy
Price Target: n/a
Current: $8.30
Upside: -
Journey Medical
Mar 6, 2018
Downgrades: Neutral
Price Target: n/a
Current: $3.63
Upside: -
Jazz Pharmaceuticals
Apr 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $109.29
Upside: -